Loading…

Decrease in Ca(2+)-sensitizing effect of UD-CG 212 Cl, a metabolite of pimobendan, under acidotic condition in canine ventricular myocardium

We studied the influence of acidosis on the positive inotropic effect of UD-CG 212 Cl (4,5-dihydro-6-[2-(4-hydroxyphenyl)-1H-benzimidazole-5-yl]-5-methyl-3(2H)-pyridazinone), an active metabolite of pimobendan, in canine ventricular trabeculae loaded with aequorin. The positive inotropic effect of U...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of pharmacology and experimental therapeutics 2001-09, Vol.298 (3), p.1060-1066
Main Authors: Takahashi, R, Shimazaki, Y, Endoh, M
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 1066
container_issue 3
container_start_page 1060
container_title The Journal of pharmacology and experimental therapeutics
container_volume 298
creator Takahashi, R
Shimazaki, Y
Endoh, M
description We studied the influence of acidosis on the positive inotropic effect of UD-CG 212 Cl (4,5-dihydro-6-[2-(4-hydroxyphenyl)-1H-benzimidazole-5-yl]-5-methyl-3(2H)-pyridazinone), an active metabolite of pimobendan, in canine ventricular trabeculae loaded with aequorin. The positive inotropic effect of UD-CG 212 Cl was markedly suppressed under acidotic conditions. The maximal contractile response to UD-CG 212 Cl was attained at 10(-5) M in the control condition at pH 7.4, but was not achieved even at 10(-4) M during acidosis. The maximal inotropic effect of UD-CG 212 Cl was 18% of the maximal response to isoproterenol (ISO(max)) in association with an increase in Ca(2+) transients of 7% of ISO(max) in the control, while they are 8 and 6% of ISO(max) under acidosis, respectively. Acidosis abolished the increase in myofilament Ca(2+) sensitivity induced by UD-CG 212 Cl, whereas the increase in Ca(2+) transients induced by the compound was not affected by acidosis. In conclusion, UD-CG 212 Cl elicited a positive inotropic effect even under acidosis, however, UD-CG 212 Cl was much less effective as a cardiotonic agent under acidosis mainly due to a decrease in the Ca(2+)-sensitizing effect under acidotic condition.
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_71096949</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71096949</sourcerecordid><originalsourceid>FETCH-LOGICAL-p122t-5e8bb5a35f03fa23244c55f25057a2b1dc3f93e39d85b96ebcce037107d566753</originalsourceid><addsrcrecordid>eNo1kNFKwzAYhXuhuDl9BcmVKK6QJk27XkrVKQy8cdflT_JHIm1Sk1SYz-BDu-G8Ohfn4ztwTrI5pYzlXFRilp3H-EFpUZYVP8tmRSFouaJ8nv08oAoIEYl1pIUbdnebR3TRJvtt3TtBY1Al4g3ZPuTtmrCCkbZfEiADJpC-twkP7WgHL9FpcEsyOY2BgLLaJ6uI8k7vdd4dJhQ465B8oUvBqqmHQIadVxC0nYaL7NRAH_HymIts-_T41j7nm9f1S3u_yceCsZQLXEkpgAtDuQHGWVkqIQwTVNTAZKEVNw1H3uiVkE2FUimkvC5orUVV1YIvsus_7xj854QxdYONCvseHPopdnu0qZqy2YNXR3CSA-puDHaAsOv-_-O_VXpq3A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71096949</pqid></control><display><type>article</type><title>Decrease in Ca(2+)-sensitizing effect of UD-CG 212 Cl, a metabolite of pimobendan, under acidotic condition in canine ventricular myocardium</title><source>Freely Accessible Journals</source><creator>Takahashi, R ; Shimazaki, Y ; Endoh, M</creator><creatorcontrib>Takahashi, R ; Shimazaki, Y ; Endoh, M</creatorcontrib><description>We studied the influence of acidosis on the positive inotropic effect of UD-CG 212 Cl (4,5-dihydro-6-[2-(4-hydroxyphenyl)-1H-benzimidazole-5-yl]-5-methyl-3(2H)-pyridazinone), an active metabolite of pimobendan, in canine ventricular trabeculae loaded with aequorin. The positive inotropic effect of UD-CG 212 Cl was markedly suppressed under acidotic conditions. The maximal contractile response to UD-CG 212 Cl was attained at 10(-5) M in the control condition at pH 7.4, but was not achieved even at 10(-4) M during acidosis. The maximal inotropic effect of UD-CG 212 Cl was 18% of the maximal response to isoproterenol (ISO(max)) in association with an increase in Ca(2+) transients of 7% of ISO(max) in the control, while they are 8 and 6% of ISO(max) under acidosis, respectively. Acidosis abolished the increase in myofilament Ca(2+) sensitivity induced by UD-CG 212 Cl, whereas the increase in Ca(2+) transients induced by the compound was not affected by acidosis. In conclusion, UD-CG 212 Cl elicited a positive inotropic effect even under acidosis, however, UD-CG 212 Cl was much less effective as a cardiotonic agent under acidosis mainly due to a decrease in the Ca(2+)-sensitizing effect under acidotic condition.</description><identifier>ISSN: 0022-3565</identifier><identifier>PMID: 11504803</identifier><language>eng</language><publisher>United States</publisher><subject>Acidosis - metabolism ; Actin Cytoskeleton - metabolism ; Aequorin - pharmacology ; Animals ; Calcium - metabolism ; Cardiotonic Agents - pharmacology ; Dogs ; Female ; Heart - drug effects ; Heart Ventricles - drug effects ; Heart Ventricles - metabolism ; In Vitro Techniques ; Male ; Myocardial Contraction - drug effects ; Myocardium - metabolism ; Pyridazines - pharmacokinetics ; Pyridazines - pharmacology</subject><ispartof>The Journal of pharmacology and experimental therapeutics, 2001-09, Vol.298 (3), p.1060-1066</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11504803$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Takahashi, R</creatorcontrib><creatorcontrib>Shimazaki, Y</creatorcontrib><creatorcontrib>Endoh, M</creatorcontrib><title>Decrease in Ca(2+)-sensitizing effect of UD-CG 212 Cl, a metabolite of pimobendan, under acidotic condition in canine ventricular myocardium</title><title>The Journal of pharmacology and experimental therapeutics</title><addtitle>J Pharmacol Exp Ther</addtitle><description>We studied the influence of acidosis on the positive inotropic effect of UD-CG 212 Cl (4,5-dihydro-6-[2-(4-hydroxyphenyl)-1H-benzimidazole-5-yl]-5-methyl-3(2H)-pyridazinone), an active metabolite of pimobendan, in canine ventricular trabeculae loaded with aequorin. The positive inotropic effect of UD-CG 212 Cl was markedly suppressed under acidotic conditions. The maximal contractile response to UD-CG 212 Cl was attained at 10(-5) M in the control condition at pH 7.4, but was not achieved even at 10(-4) M during acidosis. The maximal inotropic effect of UD-CG 212 Cl was 18% of the maximal response to isoproterenol (ISO(max)) in association with an increase in Ca(2+) transients of 7% of ISO(max) in the control, while they are 8 and 6% of ISO(max) under acidosis, respectively. Acidosis abolished the increase in myofilament Ca(2+) sensitivity induced by UD-CG 212 Cl, whereas the increase in Ca(2+) transients induced by the compound was not affected by acidosis. In conclusion, UD-CG 212 Cl elicited a positive inotropic effect even under acidosis, however, UD-CG 212 Cl was much less effective as a cardiotonic agent under acidosis mainly due to a decrease in the Ca(2+)-sensitizing effect under acidotic condition.</description><subject>Acidosis - metabolism</subject><subject>Actin Cytoskeleton - metabolism</subject><subject>Aequorin - pharmacology</subject><subject>Animals</subject><subject>Calcium - metabolism</subject><subject>Cardiotonic Agents - pharmacology</subject><subject>Dogs</subject><subject>Female</subject><subject>Heart - drug effects</subject><subject>Heart Ventricles - drug effects</subject><subject>Heart Ventricles - metabolism</subject><subject>In Vitro Techniques</subject><subject>Male</subject><subject>Myocardial Contraction - drug effects</subject><subject>Myocardium - metabolism</subject><subject>Pyridazines - pharmacokinetics</subject><subject>Pyridazines - pharmacology</subject><issn>0022-3565</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNo1kNFKwzAYhXuhuDl9BcmVKK6QJk27XkrVKQy8cdflT_JHIm1Sk1SYz-BDu-G8Ohfn4ztwTrI5pYzlXFRilp3H-EFpUZYVP8tmRSFouaJ8nv08oAoIEYl1pIUbdnebR3TRJvtt3TtBY1Al4g3ZPuTtmrCCkbZfEiADJpC-twkP7WgHL9FpcEsyOY2BgLLaJ6uI8k7vdd4dJhQ465B8oUvBqqmHQIadVxC0nYaL7NRAH_HymIts-_T41j7nm9f1S3u_yceCsZQLXEkpgAtDuQHGWVkqIQwTVNTAZKEVNw1H3uiVkE2FUimkvC5orUVV1YIvsus_7xj854QxdYONCvseHPopdnu0qZqy2YNXR3CSA-puDHaAsOv-_-O_VXpq3A</recordid><startdate>200109</startdate><enddate>200109</enddate><creator>Takahashi, R</creator><creator>Shimazaki, Y</creator><creator>Endoh, M</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200109</creationdate><title>Decrease in Ca(2+)-sensitizing effect of UD-CG 212 Cl, a metabolite of pimobendan, under acidotic condition in canine ventricular myocardium</title><author>Takahashi, R ; Shimazaki, Y ; Endoh, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p122t-5e8bb5a35f03fa23244c55f25057a2b1dc3f93e39d85b96ebcce037107d566753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Acidosis - metabolism</topic><topic>Actin Cytoskeleton - metabolism</topic><topic>Aequorin - pharmacology</topic><topic>Animals</topic><topic>Calcium - metabolism</topic><topic>Cardiotonic Agents - pharmacology</topic><topic>Dogs</topic><topic>Female</topic><topic>Heart - drug effects</topic><topic>Heart Ventricles - drug effects</topic><topic>Heart Ventricles - metabolism</topic><topic>In Vitro Techniques</topic><topic>Male</topic><topic>Myocardial Contraction - drug effects</topic><topic>Myocardium - metabolism</topic><topic>Pyridazines - pharmacokinetics</topic><topic>Pyridazines - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Takahashi, R</creatorcontrib><creatorcontrib>Shimazaki, Y</creatorcontrib><creatorcontrib>Endoh, M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of pharmacology and experimental therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Takahashi, R</au><au>Shimazaki, Y</au><au>Endoh, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Decrease in Ca(2+)-sensitizing effect of UD-CG 212 Cl, a metabolite of pimobendan, under acidotic condition in canine ventricular myocardium</atitle><jtitle>The Journal of pharmacology and experimental therapeutics</jtitle><addtitle>J Pharmacol Exp Ther</addtitle><date>2001-09</date><risdate>2001</risdate><volume>298</volume><issue>3</issue><spage>1060</spage><epage>1066</epage><pages>1060-1066</pages><issn>0022-3565</issn><abstract>We studied the influence of acidosis on the positive inotropic effect of UD-CG 212 Cl (4,5-dihydro-6-[2-(4-hydroxyphenyl)-1H-benzimidazole-5-yl]-5-methyl-3(2H)-pyridazinone), an active metabolite of pimobendan, in canine ventricular trabeculae loaded with aequorin. The positive inotropic effect of UD-CG 212 Cl was markedly suppressed under acidotic conditions. The maximal contractile response to UD-CG 212 Cl was attained at 10(-5) M in the control condition at pH 7.4, but was not achieved even at 10(-4) M during acidosis. The maximal inotropic effect of UD-CG 212 Cl was 18% of the maximal response to isoproterenol (ISO(max)) in association with an increase in Ca(2+) transients of 7% of ISO(max) in the control, while they are 8 and 6% of ISO(max) under acidosis, respectively. Acidosis abolished the increase in myofilament Ca(2+) sensitivity induced by UD-CG 212 Cl, whereas the increase in Ca(2+) transients induced by the compound was not affected by acidosis. In conclusion, UD-CG 212 Cl elicited a positive inotropic effect even under acidosis, however, UD-CG 212 Cl was much less effective as a cardiotonic agent under acidosis mainly due to a decrease in the Ca(2+)-sensitizing effect under acidotic condition.</abstract><cop>United States</cop><pmid>11504803</pmid><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-3565
ispartof The Journal of pharmacology and experimental therapeutics, 2001-09, Vol.298 (3), p.1060-1066
issn 0022-3565
language eng
recordid cdi_proquest_miscellaneous_71096949
source Freely Accessible Journals
subjects Acidosis - metabolism
Actin Cytoskeleton - metabolism
Aequorin - pharmacology
Animals
Calcium - metabolism
Cardiotonic Agents - pharmacology
Dogs
Female
Heart - drug effects
Heart Ventricles - drug effects
Heart Ventricles - metabolism
In Vitro Techniques
Male
Myocardial Contraction - drug effects
Myocardium - metabolism
Pyridazines - pharmacokinetics
Pyridazines - pharmacology
title Decrease in Ca(2+)-sensitizing effect of UD-CG 212 Cl, a metabolite of pimobendan, under acidotic condition in canine ventricular myocardium
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T23%3A31%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Decrease%20in%20Ca(2+)-sensitizing%20effect%20of%20UD-CG%20212%20Cl,%20a%20metabolite%20of%20pimobendan,%20under%20acidotic%20condition%20in%20canine%20ventricular%20myocardium&rft.jtitle=The%20Journal%20of%20pharmacology%20and%20experimental%20therapeutics&rft.au=Takahashi,%20R&rft.date=2001-09&rft.volume=298&rft.issue=3&rft.spage=1060&rft.epage=1066&rft.pages=1060-1066&rft.issn=0022-3565&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E71096949%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p122t-5e8bb5a35f03fa23244c55f25057a2b1dc3f93e39d85b96ebcce037107d566753%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=71096949&rft_id=info:pmid/11504803&rfr_iscdi=true